West Conshohocken, PA, Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- SERB Pharmaceuticals ( &#34;SERB&#34; ) , a global specialty pharmaceutical company focused on rare diseases and medical emergencies, today announced the successful completion of its acquisition of Y-mAbs Therapeutics, Inc. ( &#34;Y-mAbs&#34; ) , a ...

YMAB

<p>賓夕法尼亞州西康肖霍肯，2025 年 9 月 16 日（GLOBE NEWSWIRE）-- SERB 製藥（"SERB"），一家專注於罕見疾病和醫療緊急情況的全球專業製藥公司，今天宣佈成功完成對 Y-mAbs Therapeutics, Inc.（"Y-mAbs"）的收購，</p>

SERB 製藥完成了對 Y-mAbs Therapeutics 的收購